Prosecution Insights
Last updated: October 26, 2026

Philip Earl Stimpert, USPTO Patent Examiner

Listed by the USPTO as STIMPERT, PHILIP EARL

Tech Center 3700 • Art Units: 1723 3746 3783

This examiner grants 63% of resolved cases

Analysis

STIMPERT, PHILIP EARL is assigned to Tech Center 3700 and Art Unit 1723. His profile covers 897 resolved cases and reports an allowance rate of 63.3%. The interview lift is 48.7%, and the median time to allowance is 1293 days. The record indicates a positive association between interviews and outcomes, but also a prolonged median route to allowance.

The principal companies are Boston Scientific Corporation, DEKA Products Limited Partnership, and Cardinal Health Inc. The listed firms are SEAGER, TUFTE & WICKHEM, LLP, Maschoff Brennan (OC)(BD), and AMSTER, ROTHSTEIN & EBENSTEIN LLP. Prosecution teams can give interviews meaningful strategic attention while budgeting for the reported duration.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

63.3%
Allow Rate
-6.7% vs TC avg
968
Total Applications
+48.7%
Interview Lift
1293
Avg Prosecution Days
Based on 897 resolved cases, 2023–2026

Rejection Statute Breakdown

0.5%
§101 Eligibility
19.9%
§102 Novelty
49.3%
§103 Obviousness
28.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18631236 PUNCTURE NEEDLE, ULTRASOUND DIAGNOSTIC APPARATUS, AND CONTROL METHOD OF ULTRASOUND DIAGNOSTIC APPARATUS Final Rejection FUJIFILM Corporation
18451778 MEDICAL DEVICES HAVING CONTROLLABLY ACTUATED ANCHORING, FRICTION REDUCTION, AND DEVICE MOVEMENT Non-Final OA STRYKER EUROPEAN OPERATIONS LIMITED
18232084 CATHETER WITH RAPID EXCHANGE GUIDEWIRE PORT AND METHOD OF MANUFACTURE Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
17988192 INTRODUCER WITH SALINE ANTECHAMBER Final Rejection Boston Scientific Scimed, Inc.
17988114 DEVICES, SYSTEMS, AND METHODS FOR FLUID DELIVERY Non-Final OA Boston Scientific Scimed, Inc.
17859477 RADIALLY CLOCKED STEERABLE CATHETER Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
18163422 CATHETER AND METHOD FOR ENGAGING CATHETER Non-Final OA TERUMO KABUSHIKI KAISHA
18112455 MEDICAL BALLOON SENSING ASSEMBLY AND METHOD Final Rejection EDWARDS LIFESCIENCES CORPORATION
18163641 CLIP INDWELLING DEVICE AND CLIP Final Rejection OLYMPUS MEDICAL SYSTEMS CORP.
18283626 DUAL PIEZOELECTRIC STACK PLUNGER SUB-ASSEMBLY Final Rejection BECTON, DICKINSON AND COMPANY
18092583 Vascular Access System with Secondary Catheter Non-Final OA Becton, Dickinson and Company

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Philip Earl Stimpert's allowance rate?

63.3% of resolved applications examined by Philip Earl Stimpert were allowed (897 resolved cases), compared with 60.0% across Art Unit 1723 over the last five years.

Does an interview help with examiner Philip Earl Stimpert?

This examiner's interview lift is +48.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Philip Earl Stimpert take to allow a patent?

Applications allowed by Philip Earl Stimpert took 1,293 days on average from filing to allowance.

Which art unit does examiner Philip Earl Stimpert work in?

Philip Earl Stimpert examines applications in Art Unit 1723 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month